SummaryAs per WHO, US funding cuts could affect the drug supply chains in other countries, which are now "breaking down". Not just limited to that, but laboratory services are "severely disrupted" and surveillance systems are "collapsing", which is making it difficult to identify, monitor and treat tuberculosis cases.